Efficacy evaluation of new HPV test to improve cervical cancer screening
Not Applicable
Recruiting
- Conditions
- Diseases of the genitourinary system
- Registration Number
- KCT0009466
- Lead Sponsor
- CHA University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 3000
Inclusion Criteria
1. Cervical cytology shows atypical squamous cell (ASC) or low grade squamous cell endothelial lesion (LSIL) or normal human papillomavirus (HPV) 16 or 18 infection
2. the patients who signed an approved subject consent form
3. the patients aged 21 years or older
Exclusion Criteria
1. Patients who have previously been diagnosed with cervical cancer and precancerous lesions of the cervix and have been treated
2. Patient who is pregnant
3. Histology types other than squamous cells, linear cells and linear epithelial cells
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of HPV quantitative test results with histological results
- Secondary Outcome Measures
Name Time Method Positive predictive value of each high-risk HPV type